Quantcast

Our website use cookies to improve and personalize your experience and to display advertisements(if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, Youtube. By using the website, you consent to the use of cookies. We have updated our Privacy Policy. Please click on the button to check our Privacy Policy.

Your information is NEVER sold to a third party. 

A Coronavirus vaccine volunteer in Brazil has died after taking part in the vaccine trial

Advertisements
Share On Social Media
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  

Lending probable concern and precedence to the very real concern that a lot of people have about the vaccine, to begin with. According to Brazilian authorities, an unidentified AstraZeneca volunteer has passed away after taking part in the controversial trial that has seen hiccups occur around the world.

It remains unclear whether or not he actually received the jab because Brazilian authorities under the Bolsonaro regime can’t entirely be trusted. It is believed that he was a 28-year-old man who had openly agreed to take part in the trial for the Pharma company.

This comes as the U.S FDA recently confirmed that they will continue to hold up AstraZeneca ‘s U.S based trial amid then reports that an English man developed a rare spinal complication after having gotten the jab.

This comes amid renewed distrust among governments around the world in the fight for a trusted vaccine.

While other reports haven’t fully identified the Brazilian man, one local report has identified him as Dr João Pedro R. Feitosa a 28-year-old physician.

In a statement to NBC News, AstraZeneca also confirmed the trial would go on.

‘We cannot comment on individual cases in an ongoing trial of the Oxford vaccine as we adhere strictly to medical confidentiality and clinical trial regulations, but we can confirm that all required review processes have been followed,’ the statement said. 

‘All significant medical events are carefully assessed by trial investigators, an independent safety monitoring committee and the regulatory authorities. These assessments have not led to any concerns about continuation of the ongoing study.’  


Share On Social Media
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
By SHK

Sultan H. Khane II is the Editor-in-Chief of Bazaar Daily News and its 5 sister properties.

Leave a Reply

Related Posts

No widgets found. Go to Widget page and add the widget in Offcanvas Sidebar Widget Area.
Skip to content